OncoPath Genomics

OncoPath Genomics

OVERVIEW

The domain oncopathgenomics.com currently has a traffic classification of zero (the lower the better). We have parsed thirteen pages within the site oncopathgenomics.com and found zero websites interfacing with oncopathgenomics.com. We were able to find three contacts and locations for oncopathgenomics.com to help you reach them. The domain oncopathgenomics.com has been on the internet for seven hundred and forty-four weeks, eight days, ten hours, and fifty-seven minutes.
Pages Parsed
13
Contacts
3
Addresses
3
Online Since
Nov 2010

ONCOPATHGENOMICS.COM TRAFFIC

The domain oncopathgenomics.com has seen variant levels of traffic all over the year.
Traffic for oncopathgenomics.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for oncopathgenomics.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for oncopathgenomics.com

Date Range

All time
This Year
Last Year
Last Month

ONCOPATHGENOMICS.COM HISTORY

The domain oncopathgenomics.com was created on November 19, 2010. This website will expire on November 19, 2015. As of today, it is seven hundred and forty-four weeks, eight days, ten hours, and fifty-seven minutes old.
REGISTERED
November
2010
EXPIRED
November
2015

SITE AGE

14
YEARS
3
MONTHS
7
DAYS

LINKS TO WEBSITE

WHAT DOES ONCOPATHGENOMICS.COM LOOK LIKE?

Desktop Screenshot of oncopathgenomics.com Mobile Screenshot of oncopathgenomics.com Tablet Screenshot of oncopathgenomics.com

CONTACTS

Emmanuel Zachariah

1415 Central Avenue

Highland Park, New Jersey, 08904

United States

Emmanuel Zachariah

1415 Central Avenue

Highland Park, New Jersey, 08904

United States

YahooDomains TechContact

701 First Ave

Sunnyvale, California, 94089

United States

ONCOPATHGENOMICS.COM SERVER

We detected that a lone root page on oncopathgenomics.com took seventy-eight milliseconds to come up. We could not find a SSL certificate, so in conclusion our web crawlers consider oncopathgenomics.com not secure.
Load time
0.078 sec
SSL
NOT SECURE
IP
50.63.197.11

NAME SERVERS

ns01.domaincontrol.com
ns02.domaincontrol.com

SERVER SOFTWARE

We discovered that this website is operating the Microsoft-IIS/7.0 operating system.

SITE TITLE

OncoPath Genomics

DESCRIPTION

OncoPath Genomics

PARSED CONTENT

The domain oncopathgenomics.com states the following, "A Diagnostic Leader in personalized onco-medicine." I observed that the website stated " Providing High-Quality Gene Expression Prognostic and Predictive Services for the Personalized Medicine." They also stated " Arena to Enable Better Management of Cancer Patients. Oncopath Genomics moved to its new location at the following address. 7 Deer Park Drive,." The meta header had OncoPath as the first keyword. This keyword was followed by Genomics, Medicine, and Health which isn't as important as OncoPath. The other words the site used was Science. Emmanuel is also included but will not be seen by search engines.

ANALYZE MORE WEBSITES

oncopathologie diagnostic, prévention, traitement du cancer

Un nouveau look pour oncopathologie. Quels avis sur cette coupe? Sécurité produits. PROJET DE PLATE FORME DE PATHOLOGIE MOLECULAIRE LIBERALE.

oncopathology.info-nbsponcopathology Resources and Information.

Scientists Convert Human Skin Cells Directly Into Brain Cells. Using a finely tuned cocktail of small molecules, researchers from Washington University in St. Is an inherited brain disorder that causes the progressive degeneration of nerve cells, or neurons. As they are gradually lost in the brain, the patient experiences involuntary muscle movements.

Tratamiento infantil de enfermedades oncologicas y hematologicas

El niño y su familia. Oncología Pediátrica 902107469 Hematología Pediátrica 902089800. Unidad de Hematología y Oncología Pediátrica. La unidad de Hematología y Oncología Pediátrica del Grupo HM, y que dirige la. Como jefe clínico, está ubicada en el Hospital Universitario HM Monteprincipe. Unidad de Hematología y Oncopediatria. El próximo 29 de noviembre a las .

Oncopeptides

Work of the Board of Directors. CEO Jakob Lindberg on Oncopeptides and Ygalo. Oncopeptides is a clinical development pharmaceutical company focused on bringing anti-cancer research as treatments for the benefit of patients. Was published on February 22, 2018.